Showing results (411-420 of 438) with videos related to

Sort By:
Pageof 44
European Heart Journal|December 6, 2015
Ascertainment, classification, and impact of neoplasm detection during prolonged treatment with dual antiplatelet therapy with prasugrel vs. clopidogrel following acute coronary syndromeMatthew T Roe, Derek D Cyr, Debra Eckart, et al.
JAMA|February 15, 2007
Routine upstream initiation vs deferred selective use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: the ACUITY Timing trialGregg W Stone, Michel E Bertrand, Jeffrey W Moses, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|December 17, 2021
Impella Mechanical Circulatory Support for Takotsubo Syndrome With Shock: A Retrospective Multicenter AnalysisL Christian Napp, Ralf Westenfeld, Jacob E Møller, et al.
European Heart Journal|April 27, 2007
Effect of nitric oxide synthase inhibition on haemodynamics and outcome of patients with persistent cardiogenic shock complicating acute myocardial infarction: a phase II dose-ranging studyVladimir Dzavík, Gad Cotter, Harmony R Reynolds, et al.
International Journal of Cardiology|April 2, 2019
Does prior coronary angioplasty affect outcomes of surgical coronary revascularization? Insights from the STICH trialJose C Nicolau, Susanna R Stevens, Hussein R Al-Khalidi, et al.
JAMA|November 4, 2004
Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement InitiativeDeepak L Bhatt, Matthew T Roe, Eric D Peterson, et al.
Circulation. Cardiovascular Interventions|May 2, 2024
Angiogenic Gene Therapy for Refractory Angina: Results of the EXACT Phase 2 TrialKenta Nakamura, Timothy D Henry, Jay H Traverse, et al.
JAMA Cardiology|May 15, 2021
Sex Differences Among Patients With High Risk Receiving Ticagrelor With or Without Aspirin After Percutaneous Coronary Intervention: A Subgroup Analysis of the TWILIGHT Randomized Clinical TrialBirgit Vogel, Usman Baber, David J Cohen, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|October 17, 2024
Impact of ticagrelor with or without aspirin on total and recurrent bleeding and ischaemic events after percutaneous coronary intervention: a sub-study of the TWILIGHT trialUsman Baber, Davide Cao, Timothy Collier, et al.
European Heart Journal|October 18, 2021
Ticagrelor monotherapy in patients at high bleeding risk undergoing percutaneous coronary intervention: TWILIGHT-HBRJavier Escaned, Davide Cao, Usman Baber, et al.
Pageof 44